Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 09-Apr-2018

Apollo Health Sciences

Abstract

Antibiotic-resistant pathogens are emerging at an alarming rate. Hospitals are a major source of newly acquired multi and pan-drug resistant pathogens. New technologies must be developed that are both effective and nontoxic to combat this new scourge.

The company will work to develop a device that will dispense a long-lived antimicrobial substance to limit the incidence of hospital-contracted disease.

Additional Questions

Who is your customer?

The healthcare industry, the food manufacturing industry, the biotechnology industry, laboratories and any other market where there is a persistent need for for an automated nontoxic aerosolized sanitation solution.

What problem does this idea/product solve or what market need does it serve?

Commonly used disinfectants are often toxic, expensive and rapidly lose efficacy. This device will use proven disinfection technology in a novel way to help combat the rise of antibiotic-resistant pathogens.

What attributes will make this idea/product successful? Why do you believe that those features will create success?

This device will fill a gap in the market that is much-needed and simultaneously helps to address a growing threat to public safety. This duality of appeal to both the public and private sector will ensure the success of the product.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

Our team will have the advantage of creating one of the only nontoxic wide-dispersal antimicrobial systems. From the outset this will give our company an advantage over other devices that use toxic carcinogens like chlorine bleach or ultraviolet radiation to disinfect an area. This product will have appeal to many customers across a diverse spectrum.